Introduction
Breast cancer (BC) is a significant public health problem in South America, being the most common malignancy among women. In Brazil, BC incidence and mortality rates continue to rise despite significant efforts to establish mammographic screening programs across the country (1) .
Southern Brazilian states have particularly high incidence rates, in the range of most countries in Europe and North America, and this is likely a consequence of life style among women in this region (e.g., decreasing number of term pregnancies, significant prevalence of overweight and obesity across age groups, increasing use of hormone replacement therapy) (2) .
Other factors should also be considered, such as the influence of environmental factors and the genetic background of the population. The region has received the highest proportion of European immigrants during the last two centuries compared to other regions in Brazil (2,3).
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Several genetic polymorphisms associated with an increased risk of BC have been identified in genes involved in hormone metabolism, carcinogen metabolism as well as in some high penetrance genes such as TP53 (4) .
Polymorphisms in the STK15 gene have been recently described and an association with BC risk has been proposed. The STK15 gene (also known as AURKA, STK6, and BTAK) encodes Aurora-A, a serine-threonine kinase that acts as a key regulator of mitotic chromosome segregation and is particularly involved in the passage from the G 2 to the M phase of the cell cycle (5, 6) . Defects in chromatid segregation cause genetic instability, a condition that is clearly associated with tumorigenesis (7). Due to its regulatory function in the cell cycle, the STK15 gene has been suggested to be a potential cancer susceptibility gene. A single nucleotide polymorphism (SNP) at nucleotide 91, T>A, results in the substitution of phenylalanine by isoleucine in codon 31 (F31I) and affects the function of the STK15 gene (6) .
The first study reporting an association of the STK15 F31I polymorphism with BC described a significantly increased risk (OR = 1.76, 95%CI = 1.29-2.12) in women with the AA STK15 F31I genotype (8) . A second study reported an increase in BC risk in association with both the AT STK15 F31I (OR = 1.3, 95%CI = 1.0-1.7) and AA STK15 F31I genotypes (OR = 1.2, 95%CI = 0.9-1.6) (9). An association between overweight (body mass index, BMI ≥25) and these genotypes was also described (OR = 3.3, 95%CI = 1.4-7.7) for the AT STK15 F31I genotype and for the AA STK15 F31I genotype (OR = 4.1, 95%CI = 1.7-9.8). The same authors suggested that the association of STK15 genotype, BC risk and increased BMI could be further modified by factors related to increased endogenous exposure to estrogen, including enhanced peripheral metabolism, early menarche, late menopause, and later age at first childbirth. However, additional studies have reported an association between the AA STK15 F31I genotype and overall BC risk in relation to BMI. Results are conflicting, with increased risk being associated with postmenopausal women with and without an increased BMI (9) (10) (11) .
No association between the STK15 F31I polymorphism and mammographic density was identified in the literature. The mammographic density (radiological breast density) is influenced by the hormonal changes that occur throughout the life of women and is considered to be one of the most important independent risk factor for breast cancer (12) . Hormonal changes reflect persistent differences in cell cycle regulators, signal transduction pathways, transcription factors, and other unknown regulatory molecules.
Thus, the objective of the present study was to determine the allelic and genotypic frequencies of the STK15 F31I polymorphism in 750 healthy women and also to investigate the relationship of this polymorphism with breast cancer risk factors, including mammographic density.
Material and Methods

Study population and data collection
A consecutive and unselected sample of 750 breast cancer-unaffected women (ages 40-69 years) enrolled in a mammography screening program in the city of Porto Alegre (Núcleo Mama Porto Alegre -NMPOA Cohort) was recruited for this study during routine mammographic visits for 4 months (13, 14) . Study approval was obtained from the Ethics Committees of the participating institutions, Hospital de Clínicas de Porto Alegre and Associação Hospitalar Moinhos de Vento, and all individuals recruited for the study gave written informed consent. Demographic and clinical information as well as results from mammographic screening were obtained from chart review. We also started a prospective DNA collection of all breast cancer cases identified within the program and present here preliminary results of the analysis of the first 39 cases recruited.
Study variables
Study variables included age at recruitment, age at first childbirth, age at menarche and menopause, parity, BMI (classified into 4 categories: <18.5; ≥18.5-24.99; 25-29.99; ≥30), race (white or non-white, assessed by selfclassification), results of the mammographic examination and mammographic density (using the BI-RADS and breast density categories of the American College of Radiology 1998), previous breast biopsies, use of hormone replacement therapy (HRT) and/or oral contraceptives, estimated 5-year risk (Gail 5-years) and estimated lifetime risk of developing cancer according to the Gail model (15, 16) .
Polymorphism analysis
Genomic DNA was obtained from peripheral blood samples using standard methods (17) . Genotyping was performed using the TaqMan PCR assay for STK15 F31I polymorphism (rs2273535, C_25623289_10 Applied Biosystems, USA), with fluorescent minor groove binding probes. Analyses were performed using an ABI 7500 real-time PCR system (Applied Biosystems), and results were analyzed with the Sequence Detection software v 1.4 (Applied Biosystems).
Statistical analysis
SPSS version 14.0 was used for data handling and statistical analyses. For descriptive analysis, categorical variables were described by their absolute and/or relative frequencies and quantitative variables are reported as means + SD. For analytical statistics, the t-test for independent variables and ANOVA were used to compare the mean values of the quantitative variables. The existence of an association between categorical variables was examined by the chi-square test. The level of significance of 0.05 was adopted in all analyses. Comparative analysis of genotypic frequencies between this and other studies was done using the WINPEPI package (PEPI-for-Windows) (18) .
Results
Data regarding the BC risk factors identified in the sample are presented in Table 1 . Mean age (± SD) at inclusion of the women enrolled in the present study was 51 ± 7.6 years, 420 (56.0%) women were postmenopausal, and the mean estimated lifetime risk of developing BC in the overall sample using the Gail model was 7.8 ± 3.3%. *There was considered to be a family history (FH) of breast cancer if the answer to one of these questions was positive: 1) FH of breast or ovarian cancer in 1st degree relatives; 2) FH of bilateral breast cancer; 3) any man in the family with breast cancer; 4) any woman in the family with breast and ovarian cancer; 5) any woman in the family with breast cancer before the age of 50 years; 6) two or more relatives with breast and/or ovarian cancer; 7) two or more relatives with breast and/or bowel cancer. Table 2 . Genotypic and allelic frequencies of the STK15 F31I polymorphism in the overall sample (N = 750), and in white (N = 599) and non-white women (N = 151). The allelic and genotypic frequencies of the STK15 F31I polymorphism are presented in Table 2 . The distribution of genotypes for this polymorphism in the overall sample, as well as that of the self-denominated groups of white and non-white women was consistent with Hardy-Weinberg equilibrium (H-W: 3.22, 3.83, 0.02, respectively). There were no significant differences in observed allelic and genotypic frequencies between white and non-white women (P > 0.05).
The STK15 F31I AT and AA genotypes were encountered significantly more often in premenopausal women with moderately dense, dense and heterogeneously dense breast tissue (P = 0.023). In addition, the presence of the STK15 F31I TT genotype was significantly associated with age at menarche ≥12 years (P = 0.023). No significant associations with other breast cancer risk factors were identified.
Interestingly, preliminary results of the first 39 BC patients identified within this cohort of 750 women showed that the genotypic frequencies were significantly different between cases and controls (especially for the TT and AA genotypes). This difference is striking and in favor of a role of STK15 as an independent risk factor for BC as previously suggested by other investigators. Assessment of this polymorphism in a larger series of BC patients from the same community is needed, however, to confirm these results.
Discussion
Several studies have now identified the STK15 F31I polymorphism as a low-penetrance risk allele for BC, but its association with clinical characteristics or with mammographic density in a Brazilian population has not been determined. Compelled by a possible association of the STK15 F31I polymorphism with these variables, we performed the present study in a population-based sample of women submitted to mammographic screening from a geographic area of Brazil with high BC incidence rates.
The genotypic frequencies encountered in this study were similar to those described in other predominantly European populations (6, 11, 19, 20) and significantly distinct from those observed among Asians (Table 3) . This is not unexpected because, although the contemporary Brazilian population is highly admixed, there is a predominance of European alleles, especially in the formation of the genetic pool of Southern Brazil where this study was carried out. Price et al. (22) , for instance, have estimated that African and European ancestry corresponds to 11 and 71% of the alleles in Brazilian individuals and Alves-Silva et al. (23) described a major contribution of European alleles to both mitochondrial (66%) and nuclear (79%) DNA in populations from Southern Brazil. An interesting observation is that the frequency of homozygotes for the STK15 F31I A allele (risk genotype AA) is 7-fold higher in the Asian (Chinese) populations studied so far than in the sample studied here and other European populations. In Chinese women, BC incidence rates are significantly lower than those observed in Western countries and in Brazil (24) .
In addition, the presence of the STK15 F31I TT genotype was significantly associated with age at menarche ≥12 years (P = 0.023). No significant association was found between the STK15 F31I polymorphism and age at menopause, age at first childbirth, BMI or use of HRT.
We also investigated a possible association between the STK15 F31I polymorphism and indicators of prolonged estrogen exposure. Breast cancer is a hormone-related tumor, and it is well established that sex hormones increase breast cancer risk (and modify the mammographic density) by increasing proliferation of breast epithelial cells. It has also been suggested that loss of function of certain STK15 alleles could potentially be enhanced in women with higher exposure, either endogenous or exogenous, to the mitogenic influence of estrogen (25) (26) (27) . The STK15 F31I risk genotypes AT and AA were encountered significantly more often in premenopausal women with moderately dense, dense and heterogeneously dense breast tissue (P = 0.023). Replication errors and genetic damage during cell division, if not corrected, may lead to breast cancer. In experimental studies, overexpression of STK15 in non-malignant cultured cells leads to centrosome amplification, chromosome instability, transformation and the ability to induce tumors. In addition, amplification and/or overexpression of STK15 has been reported in cancer cell lines and in several human tumors, including breast cancer. Although the functional significance of allele A of the STK15 F31I polymorphism has not been fully determined, some publications have reported that this allele is associated with accelerated growth and proliferation of tumor cells in culture. In the present study, we suggest that women with the A allele, associated with increased expression of STK15, experience high proliferation of breast epithelial cells and this would be the biologic rationale for the observed increase in breast density. The increased risk for breast cancer associated with higher breast density could be related to the biologic observation of accelerated cell proliferation and/or due to the difficulties in assessing dense breast tissue by conventional screening methods (i.e., mammography) (9, (25) (26) (27) .
Since mammographic density directly reflects the status of breast parenchyma and stroma, it is reasonable to suggest that increased breast density may be associated with increased breast cancer risk due to an increased number of epithelial cells and/or an increased proliferative state of these cells. In this setting, the AT and AA genotypes of STK15 polymorphism F31I could be associated with increased breast cancer risk through increased expression of the gene. Multiple factors influence the mammographic pattern, including age, reproductive history, hormone levels, and body constitution. In this study, we demonstrate that a genetic polymorphism is associated with increased breast density. The genetic determinants of breast density are being extensively studied and this is a promising area of research, since identification of an "intrinsic" determinant of increased breast density could also potentially be a risk factor for breast cancer.
Further investigation of the STK15 F31I polymorphism in other populations and especially, in case-control studies of women with or without breast cancer are necessary to establish whether it has a role as a genetic risk factor for this disease.
We conclude that the genotypic frequencies observed in the sample of 750 healthy women from Southern Brazil studied here were similar to those described in other predominantly European populations. High mammographic density was encountered more frequently in premenopausal women with the STK15 F31I risk genotypes AA and AT, suggesting that this polymorphism has a phenotypic effect and may play an important role in breast cancer risk determination. Furthermore, this study adds to current knowledge that genetic determinants of mammographic density may be useful in building multigenic models for predicting breast cancer risk. Finally, if confirmed, the associations between STK15 F31I risk genotypes and high mammographic density in premenopausal women could have important implications for mammographic screening strategies in this and other populations. Additional case-control studies are necessary to confirm the findings described here.
